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Table 1. Costs 2011–2012 
NHS Reference Costs 2011-129 
Admission Type Currency code Currency description Activity* 
National 
average 
unit cost 
Number of 
bed days 
Average 
length of 
stay 
(days) 
Elective Inpatient 
HRG Data KA03A 
Parathyroid procedures with 
CC 1,859 £2,648 3,229 1.74 
Non-Elective 
Inpatient HRG Data KA03A 
Parathyroid procedures with 
CC 75 £3,431 268 3.57 
Elective Inpatient 
Excess Bed Day 
HRG Data 
KA03A Parathyroid procedures with CC 647 £276   
Non-Elective 
Inpatient Excess 
Bed Day HRG Data 
KA03A Parathyroid procedures with CC 821 £254   
* Activity records the number of patients admitted to hospital for that specific currency and admission type 
 
NHS Payment by Results National Tariff 2011-128 
Admission Type HRG Code HRG Name  Tariff  
Trimpoint 
(days)* 
Elective Inpatient 
HRG KA03A 
Parathyroid procedures with 
CC  £2,481  6 
Non-Elective 
Inpatient HRG KA03A 
Parathyroid procedures with 
CC  £6,202  65 
Inpatient Excess 
Bed KA03A 
Parathyroid procedures with 
CC  £200   
* The trimpoint relates to the average length of stay to which this tariff applies, hospital stays beyond this trimpoint incur an excess stay payment 
 
Laboratory Tests 
Test Cost per unit Source 
Ultrasound £145 Cardiff & Vale Hospital Board 
Nuclear medicine £145 Cardiff & Vale Hospital Board 
Parathyroid Hormone (PTH) £21.15 Garside 200716 
Calcium £2.84 Cardiff & Vale Hospital Board 
Computerised Tomography 
(CT)/Magnetic Resonance Imaging (MRI) £144.09 NHS Reference Costs 2010-2011
9 
Electrocardiogram (ECG) £36.67 NHS Reference Costs 2010-20119 
Chest X-Ray £86.52 Kidney Care 201117 
Full Blood Count (FBC) £4.57 Kidney Care 201117 
Renal Profile £4.11 Kidney Care 201117 
Liver Profile £4.20 Kidney Care 201117 
Glucose level £1.23 Cardiff & Vale Hospital Board 
Lipid levels £1.99 Cardiff & Vale Hospital Board 
Calcium Phosphate £2.84 Cardiff & Vale Hospital Board 
Abbreviations: HRG: Healthcare Resource Group, CC: Complications,  
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Table 2. Patient demographics 
 Database Questionnaires 
Period 2000-08 2010 
Number 124 79 
Age 51.1 (13.8) 53.0 (6.0) 
Male 46.8% - 
Cause of ESRD 
Chronic Renal Failure 38.7% - 
IgA Nephropathy 11.3% 
Polycystic Kidney Disease 6.5% 
Renal vascular disease due 
to hypertension 6.5% 
Other causes 37.0% 
Length of ESRD Therapy 87.4 months 47.3 months 
Dialysis 
Haemodialysis 46.0% 62.8% 
Peritoneal dialysis 27.6% 17.0% 
Abbreviations: ESRD: End Stage Renal Disease 
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Table 3. Hospital visits, tests, and medications 
 Pre-Surgical Surgical Peri-Surgical 
 Database Questionnaires Database Questionnaires Database Questionnaires 
Hospital visits, n 1* 1.1 
(centre mean 1.3) 
- - 1* 7.2 
(centre mean 7.7) 
GP visits, n - - - - - 2.4 
(centre mean 12.0) 
Test, % patients (n 
tests) 
Database Questionnaires Database Questionnaires Database Questionnaires 
Ultrasound - 50.8 (1, 0.4) - 16.7 (6.0, 0.5) - 0 (-) 
Nuclear medicine - 35.8 (1, 0.3) - 0 (-) - 0 (-) 
CT/MRI - 1.8 (1, 0.02) - 0 (-) - - 
PTH 45.2 (1.8) 100 (1.8, 1.7) 19.4 (1.6) 70.8 (1.9, 1.1) 23.4 (1.6) 91.7 (2.0, 1.5) 
Calcium 71.0 (4.4) 83.3 (3.1, 2.2) 71.8 (12.2) 66.7 (5.6, 3.8) 60.5 (5.3) 83.3 (8.2, 7.5) 
Chest X-ray - 83.3 (1, 0.9) - - - - 
ECG - 100 (1, 1) - - - - 
FBC 71.8 (5.8) 100 (3.6, 2.7) 59.7 (4.9) 75.0 (2.9, 1.7) 43.5 (4.7) 100 (3.3, 4.2) 
Renal profile 71.8 (5.6) 100 (6.1, 4.3) 67.7 (6.0) 60.0 (3.3, 1.9) 54.8 (3.8) 100 (4.5, 5.2) 
Liver profile 71.8 (4.9) 100 (3.3, 2.4) 71.8 (6.4) 70.8 (2.5, 1.4) 61.3 (5.4) 66.7 (2.8, 1.2) 
Glucose levels 61.3 (3.4) 85.0 (2.1, 1.5) 33.1 (2.4) 35.0 (3.5, 0.9) 33.9 (3.3) 48.3 (2.3, 0.7) 
Lipid levels 32.3 (1.5) 53.3 (1.3, 0.9) 0.8 (1.0) 1.7 (1.0, 0.01) 12.1 (1.1) 11.7 (1.0, 0.1) 
Calcium phosphate 71.0 (4.8) 88.3 (2.8, 2.3) 51.6 (4.7) 66.7 (3.9, 1.7) 53.2 (4.6) 66.7 (7.0, 3.0) 
Medications, % 
patients, dose, 
duration 
Database Questionnaires^ Database Questionnaires^ Database Questionnaires^ 
Calcium 16.1, 1.3 g, 
88.0 days 
56.7, 1.4 g, 45.9 days 
(47.5, 4.8 g, 69 days) 
21.8, 2.5 g, 5.6 days 100, 4.8 g, 2.8 days 
(100, 4.0 g, 3.9 days) 
56.5, 2.7 g, 16.6 days 87.5, 4.7 g, 26.2 days 
(79.7, 4.4 g, 24.6 days) 
Vitamin D 35.5, 1 µg, 
80.5 days 
79.7, 1.6 µg, 9.7 days 
(77.5, 2.9 µg, 20 days) 
42.7, 2 µg, 6.5 days 100, 3.6 µg, 2.8 days 
(100, 3.7 µg, 3.9 days) 
84.7, 3 µg, 19.0 days 92.4, 3.1 µg, 29.7 days 
(87.5, 3.0 µg, 25.5 days) 
Calcium & Vitamin D - 54.2, 0.8 µg, 40.2 days 
(38.3, 2.5 µg, 61.7 days) 
- 30.4, 1.4 µg, 6.0 days 
(33.3, 6.0 µg, 6.0 days) 
- 30.4, 1.3 µg, 7.7 days 
(33.3 5.5 µg, 19.5 days) 
Phosphate binders 15.3, 2.5 g, 
81.6 days 
66.3, 2.3 g, 48.8 days 
(54.2, 6.6 g, 80 days) 
15.3, 2.6 g, 5.7 days  67.9, 2.4 g, 2.6 days 
(64.2, 3.2 g, 4.7 days) 
15.3, 2.6 g, 30.1 days 27.7, 0.6 g, 7.2 days 
(43.4, 3.5 g, 23 days) 
Cinacalcet - 47.3, 0.01 g, 42.6 days 
(35.0, 0.08 g, 90 days) 
- - - - 
Antibiotics - - 17.7, 1.5 g, 5.6 days - 23.4, 1.4 g, 19.8 days - 
Analgesics - - 47.6, 2.7 g, 5.8 days - 50.0, 2.7 g, 29.3 days - 
*estimated by physician  ^centre means provided in parentheses.  
Abbreviations:  GP: General Practitioner, CT/MRI: Computerised Tomography/ Magnetic Resonance Imaging, PTH: Parathyroid Hormone, ECG: Electrocardiogram, FBC: Full Blood Count, 
 
